Visby Medical Revenue and Competitors

Location

$383.7M

Total Funding

Estimated Revenue & Valuation

  • Visby Medical's estimated annual revenue is currently $35M per year.(i)
  • Visby Medical's estimated revenue per employee is $167,464
  • Visby Medical's total funding is $383.7M.
  • Visby Medical's current valuation is $1.1B. (March 2022)

Employee Data

  • Visby Medical has 209 Employees.(i)
  • Visby Medical grew their employee count by 0% last year.

Visby Medical's People

NameTitleEmail/Phone
1
Founder and CEOReveal Email/Phone
2
SVP Quality, Regulatory and Clinical AffairsReveal Email/Phone
3
SVP Manufacturing and OperationsReveal Email/Phone
4
SVP Research and DevelopmentReveal Email/Phone
5
Head Information Technology(CIO Scope)Reveal Email/Phone
6
VP FinanceReveal Email/Phone
7
Director Product TransferReveal Email/Phone
8
Director Rewards & Employee ExperienceReveal Email/Phone
9
Sr. Director EngineeringReveal Email/Phone
10
Director AssayReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M99-1%$38.2MN/A
#2
$35M2090%$383.7MN/A
#3
$15M2361%$100MN/A
Add Company

What Is Visby Medical?

Driven by a belief that results should be quick, accurate, and accessible to all, we are developing a device platform that aims to redefine the way we test and treat illness.

keywords:N/A

$383.7M

Total Funding

209

Number of Employees

$35M

Revenue (est)

0%

Employee Growth %

$1.1B

Valuation

N/A

Accelerator

Visby Medical News

2022-03-22 - Visby Medical receives funding for at-home Flu-COVID PCR ...

Visby Medical has secured additional funding of $25.5m from the US Biomedical Advanced Research and Development Authority (BARDA) to develop...

2022-03-22 - Visby Medical triggers $25.5M contract option with BARDA to ...

Visby said it designed its developmental-stage flu-COVID-19 PCR test as a single-use, handheld, all-in-one device for detecting and...

2022-03-22 - Visby Medical Executes Contract Option with BARDA for $25.5 ...

Visby Medical is accelerating the delivery of fast and accurate, palm-sized PCR diagnostics to the point of care, and eventually for use at home...

2021-09-13 - FDA Grants Emergency Use Authorization for Visby Medical's COVID-19 RT-PCR Test for Pooled Samples

SAN JOSE, Calif., Sept. 13, 2021 /PRNewswire/ -- Visby Medical™ announced today that its instrument-free Reverse Transcription (RT)-Polymerase Chain Reaction (PCR) COVID-19 test was granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for testing pooled pati ...

2020-10-13 - Visby Medical's Personal PCR Receives Funding from National Institute of Health, RADx Program

SAN JOSE, Calif., Oct. 13, 2020 /PRNewswire/ -- Visby Medical™, an infectious disease diagnostic company, received Phase 2 funding from the National Institutes of Health (NIH) as part of its Rapid Acceleration of Diagnostics (RADx) initiative. The RADx initiative aims to combat SARS-CoV-2 and ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$42M2091%N/A
#2
$74.7M209-1%N/A
#3
$7.5M210-9%$127.8M
#4
$62.2M212-18%$575.2M
#5
N/A2123433%N/A